Hanlin Gao - 23 Feb 2026 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role: Chief Scientific Officer
Signature: /s/ Paul Kim as Attorney-in-Fact
Issuer symbol: FLGT
Transactions as of: 23 Feb 2026
Net transactions value: -$362,527
Form type: 4
Filing time: 25 Feb 2026, 20:17:59 UTC
Previous filing: 28 Jan 2026
Next filing: 02 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Gao Hanlin	Chief Scientific Officer	C/O FULGENT GENETICS, INC., 4399 SANTA ANITA AVENUE, EL MONTE	/s/ Paul Kim as Attorney-in-Fact	25 Feb 2026	0001684532

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FLGT	Common Stock	Tax liability	$9,273	-403	-0.04%	$23.01	951,156	23 Feb 2026	Direct	F1
transaction	FLGT	Common Stock	Award	$0	+4,891	+0.51%	$0.000000	956,047	24 Feb 2026	Direct	F2
transaction	FLGT	Common Stock	Award	$0	+12,762	+1.3%	$0.000000	968,809	24 Feb 2026	Direct	F3
transaction	FLGT	Common Stock	Award	$0	+22,806	+2.4%	$0.000000	991,615	24 Feb 2026	Direct	F4
transaction	FLGT	Common Stock	Tax liability	$57,471	-2,489	-0.25%	$23.09	989,126	24 Feb 2026	Direct	F5
transaction	FLGT	Common Stock	Tax liability	$107,622	-4,661	-0.47%	$23.09	984,465	24 Feb 2026	Direct	F6
transaction	FLGT	Common Stock	Tax liability	$188,160	-8,149	-0.83%	$23.09	976,316	24 Feb 2026	Direct	F7
transaction	FLGT	Common Stock	Award	$0	+26,661	+2.7%	$0.000000	1,002,977	24 Feb 2026	Direct	F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2023, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 27, 2023.
F2	Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 23, 2023.
F3	Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 26, 2024.
F4	Performance-based restricted stock units. The shares vested pursuant to certain performance milestones for performance-based restricted stock units granted on February 25, 2025.
F5	The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 23, 2023.
F6	The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 26, 2024.
F7	The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of the above performance-based restricted stock units granted to the reporting person on February 25, 2025.
F8	Restricted stock units. The shares subject to the restricted stock units vest over a period of three years, with 1/3rd of such shares vesting 12 months after March 1, 2026, and 1/12th of such shares vesting at the end of every three-month period thereafter over the remaining 24 months, subject to continued service for Issuer on each vesting date.